O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver

Diabetes

Volumn 60, Issue 5, 2011, Pages 1399-1413

  Guinez, Céline ^a,b,c,e   Filhoulaud, Gaëlle ^a,b,c   Rayah Benhamed, Fadila ^a,b,c   Marmier, Solenne ^a,b,c   Dubuquoy, Céline ^a,b,c   Dentin, Renaud ^a,b,c   Moldes, Marthe ^a,b,c   Burnol, Anne Françoise ^a,b,c   Yang, Xiaoyong ^d   Lefebvre, Tony ^e   Girard, Jean ^a,b,c   Postic, Catherine ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; MONOSACCHARIDE; N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE; SERINE; THREONINE; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; FATTY LIVER; GENE EXPRESSION; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL; MALE; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; FATTY LIVER; HEP G2 CELLS; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER; MALE; MICE; MICE, INBRED C57BL; N-ACETYLGLUCOSAMINYLTRANSFERASES; NUCLEAR PROTEINS; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 79959473762     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0452     Document Type: Article

References (38)

1. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-838 (Pubitemid 351364588)
2. Dentin R, Pégorier JP, Benhamed F, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 2004;279:20314-20326 (Pubitemid 38623477)
3. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci U S A 2004;101:15597-15602 (Pubitemid 39473533)
4. Ma L, Tsatsos NG, Towle HC. Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes. J Biol Chem 2005;280:12019-12027 (Pubitemid 40418520)
5. Dentin R, Benhamed F, Hainault I, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 2006;55:2159-2170 (Pubitemid 44743612)
6. Iizuka K, Miller B, Uyeda K. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 2006;291:E358-E364 (Pubitemid 44043073)
7. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 2003;100:5107-5112 (Pubitemid 36542666)
8. Denechaud PD, Bossard P, Lobaccaro JM, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008;118:956-964 (Pubitemid 351364603)
9. Tsatsos NG, Towle HC. Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun 2006; 340:449-456 (Pubitemid 43021769)
10. Issad T, Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol Metab 2008;19:380-389
11. Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008;319:1402-1405 (Pubitemid 351354877)
12. Housley MP, Rodgers JT, Udeshi ND, et al. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 2008;283:16283-16292
13. Housley MP, Udeshi ND, Rodgers JT, et al. A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 2009;284:5148-5157
14. Anthonisen EH, Berven L, Holm S, Nygård M, Nebb HI, Grønning-Wang LM. Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem 2010;285:1607-1615
15. Ozcan S, Andrali SS, Cantrell JE. Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 2010;1799:353-364
16. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003;423:550-555 (Pubitemid 36648580)
17. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005;437:1109-1111
18. Kuo M, Zilberfarb V, Gangneux N, Christeff N, Issad T. O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett 2008;582:829-834
19. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 2010;123:13-22
20. Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N- acetylglucosamine on nucleocytoplasmic proteins. Nature 2007;446:1017-1022 (Pubitemid 46676063)
21. Love DC, Hanover JA. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005;2005:re13
22. Guinez C, Morelle W, Michalski JC, Lefebvre T. O-GlcNAc glycosylation: a signal for the nuclear transport of cytosolic proteins? Int J Biochem Cell Biol 2005;37:765-774
23. Marshall S, Garvey WT, Traxinger RR. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J 1991;5:3031-3036 (Pubitemid 21892862)
24. Yang X, Ongusaha PP, Miles PD, et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 2008;451:964-969 (Pubitemid 351301737)
25. Lou DQ, Tannour M, Selig L, Thomas D, Kahn A, Vasseur-Cognet M. Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response. J Biol Chem 1999;274: 28385-28394
26. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975;5:19-27
27. Stoeckman AK, Ma L, Towle HC. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 2004;279:15662-15669 (Pubitemid 38618968)
28. Pedersen KB, Zhang P, Doumen C, et al. The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions. Am J Physiol Endocrinol Metab 2007; 292:E788-E801 (Pubitemid 46411057)
29. Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 2005;87:81-86 (Pubitemid 40298769)
30. Soesanto YA, Luo B, Jones D, et al. Regulation of Akt signaling by O-GlcNAc in euglycemia. Am J Physiol Endocrinol Metab 2008;295:E974-E980
31. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 2010;120:4316-4331
32. Butkinaree C, Park K, Hart GW. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 2010;1800:96-106
33. Karunakaran U, Jeoung NH. O-GlcNAc modification: friend or foe in diabetic cardiovascular disease. Korean Diabetes J 2010;34:211-219
34. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001;98:9116-9121 (Pubitemid 32743878)
35. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003;115: 715-725 (Pubitemid 38030300)
36. Li MV, Chen W, Harmancey RN, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun 2010;395:395-400
37. Li MV, Chang B, Imamura M, Poungvarin N, Chan L. Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 2006;55:1179-1189 (Pubitemid 44195353)
38. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:370-379